SEC 13F Intelligence

Managers / Q4 2022 · view latest →

NVP Associates, LLC

CIK 0001545692 · 1300 EL CAMINO REAL, SUITE 200, MENLO PARK, CA, 94025 · 650-321-8000

Reported Value
$102M
Q4 2022
Positions
8
Filings on Record
14
2019–present window
Filed
Feb 14, 2023
original filing

Summary

Nvp Associates, LLC reported $102M in U.S.-listed holdings across 8 positions for Q4 2022.

The portfolio is heavily concentrated: 7WH alone accounts for 64.1% of reported value.

Portfolio Metrics

Largest Position
+64.1%
Udemy

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’22: $102MQ4 ’22Q1 ’23: $87MQ2 ’23: $115MQ2 ’23Q3 ’23: $112MQ4 ’23: $112MQ4 ’23Q1 ’24: $126MQ2 ’24: $91MQ2 ’24Q3 ’24: $176MQ4 ’24: $187MQ4 ’24Q1 ’25: $112MQ2 ’25: $184MQ2 ’25Q3 ’25: $166MQ4 ’25: $255MQ4 ’25Q1 ’26: $176Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 88.9%Other: 11.1%
  • Common Stock · 88.9% · $91M
  • Other · 11.1% · $11M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
7WHUDEMY INCNEW+6.23M6.23M+$66M$66M
IMPEL PHARMACEUTICALS INCNEW+3.08M3.08M+$12M$12M
TALKTALKSPACE INCNEW+14.70M14.70M+$9M$9M
GROVE COLLABORATIVE HOLD INCNEW+14.72M14.72M+$6M$6M
DAVE INCNEW+18.65M18.65M+$5M$5M
OPENOPENDOOR TECHNOLOGIES INCNEW+4.19M4.19M+$5M$5M
DIGITAL BRANDS GROUP INCNEW+15.9K15.9K+$67,258$67,258
BORQS TECHNOLOGIES INCNEW+101.1K101.1K+$21,049$21,049

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2022

8 positions
#IssuerClass% PortfolioValueShares
17WHUDEMY INChistory →COM64.14%$66M6.23M
2IMPEL PHARMACEUTICALS INCCOM11.26%$12M3.08M
3TALKTALKSPACE INChistory →COM8.76%$9M14.70M
4GROVE COLLABORATIVE HOLD INCCOM CL A5.73%$6M14.72M
5DAVE INCCLASS A COM5.28%$5M18.65M
6OPENOPENDOOR TECHNOLOGIES INChistory →COM4.74%$5M4.19M
7DIGITAL BRANDS GROUP INCCOM NEW0.07%$67,25815.9K
8BORQS TECHNOLOGIES INCSHS NEW0.02%$21,049101.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$176M5May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$255M6Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$166M5Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$184M7Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$112M6May 12, 202513F-HRchanges · EDGAR ↗
Q4 2024$187M7Feb 10, 202513F-HRchanges · EDGAR ↗
Q3 2024$176M8Nov 12, 202413F-HRchanges · EDGAR ↗
Q2 2024$91M6Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$126M6May 10, 202413F-HRchanges · EDGAR ↗
Q4 2023$112M6Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$112M8Nov 8, 202313F-HRchanges · EDGAR ↗
Q2 2023$115M9Aug 1, 202313F-HRchanges · EDGAR ↗
Q1 2023$87M8May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$102M8Feb 14, 202313F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.